Daiwa SB Investments’s Bristol-Myers Squibb BMY Stock Holding History

Daiwa SB Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,245	Closed	-$285K	–	247
2017 Q1	$285K	Sell	5,245 -145,805	-97%	-$8M	0.08%	115
2016 Q4	$8.83M	Sell	151,050 -12,540	-8%	-$686K	2.32%	17
2016 Q3	$8.82M	Sell	163,590 -180	-0.1%	-$11.6K	2.28%	18
2016 Q2	$12M	Sell	163,770 -10,170	-6%	-$719K	3.46%	1
2016 Q1	$11.1M	Sell	173,940 -6,567	-4%	-$414K	2.82%	3
2015 Q4	$12.4M	Sell	180,507 -7,121	-4%	-$471K	2.9%	3
2015 Q3	$11.1M	Sell	187,628 -8,462	-4%	-$537K	2.54%	4
2015 Q2	$13M	Sell	196,090 -12,720	-6%	-$838K	2.54%	6
2015 Q1	$13.5M	Sell	208,810 -21,976	-10%	-$1.38M	2.41%	4
2014 Q4	$13.6M	Sell	230,786 -28,034	-11%	-$1.58M	2.18%	7
2014 Q3	$13.2M	Buy	+258,820	New	+$12.9M	1.66%	14
2014 Q2	–	Sell	-216,300	Closed	-$11.2M	–	121
2014 Q1	$11.2M	Hold	216,300	–	–	1.34%	28
2013 Q4	$11.5M	Sell	216,300 -125,983	-37%	-$6.42M	1.29%	29
2013 Q3	$15.8M	Buy	342,283 +5,808	+2%	+$255K	1.81%	8
2013 Q2	$15M	Buy	+336,475	New	+$14.6M	2.55%	11

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Daiwa SB Investments's BMY Position: Q2 2017 in Review

Daiwa SB Investments sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 5,245 shares — an estimated $285K sold.

Daiwa SB Investments first reported a position in BMY in Q2 2013 and held it in 15 quarters. The position peaked at $15.8M in Q3 2013. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Daiwa SB Investments reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
Daiwa SB Investments sold 5,245 Bristol-Myers Squibb shares in Q2 2017, an estimated $285K.
Daiwa SB Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 15 quarters.
Daiwa SB Investments's Bristol-Myers Squibb position peaked at $15.8M in Q3 2013.
1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Daiwa SB Investments's 13F filing for Q2 2017, filed 11 Jul 2017.